Clinical Trial Update: Safety and Efficacy of Human Autologous Peripheral Blood Stem Cells for Treatment of HBV-related Liver Cirrhosis [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial investigates autologous peripheral blood stem cell therapy for HBV-related liver cirrhosis, reporting safety and efficacy data; curre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Liver Disease
• Liver Cirrhosis

Drugs mentioned

• Autologous peripheral blood stem cell therapy (autologous peripheral blood stem cells)

Snippet

Sponsor: Air Force Military Medical University, China | Conditions: Liver Cirrhosis, End Stage Liver Disease | Phase 1, Phase 2 | Status: UNKNOWN